These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31188467)

  • 1. Real-World Data: An Unrealized Opportunity in Global Health?
    Barrett JS; Heaton PM
    Clin Pharmacol Ther; 2019 Jul; 106(1):57-59. PubMed ID: 31188467
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?
    Van Driest SL; Choi L
    Clin Pharmacol Ther; 2019 Jul; 106(1):84-86. PubMed ID: 30942897
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings of a Workshop: US Food and Drug Administration-International Society of Pharmacometrics Model-Informed Drug Development in Oncology.
    Bruno R; Jin JY; Maxfield K; Milligan L; Liu C; Wang Y; McKee AE; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):81-83. PubMed ID: 30951201
    [No Abstract]   [Full Text] [Related]  

  • 4. The US Food and Drug Administration's Model-Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact.
    Madabushi R; Benjamin JM; Grewal R; Pacanowski MA; Strauss DG; Wang Y; Zhu H; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):74-78. PubMed ID: 31081932
    [No Abstract]   [Full Text] [Related]  

  • 5. Method transfer: a CRO perspective.
    Hilhorst MJ; van der Strate BW; Briscoe CJ; van de Merbel NC
    Bioanalysis; 2017 Aug; 9(15):1131-1134. PubMed ID: 28763238
    [No Abstract]   [Full Text] [Related]  

  • 6. Model-Informed Drug Development: A Regulatory Perspective on Progress.
    Zhu H; Huang SM; Madabushi R; Strauss DG; Wang Y; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):91-93. PubMed ID: 31162631
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug Administration.
    Reaman G; Karres D; Ligas F; Lesa G; Casey D; Ehrlich L; Norga K; Pazdur R
    J Clin Oncol; 2020 Dec; 38(36):4227-4230. PubMed ID: 32946356
    [No Abstract]   [Full Text] [Related]  

  • 8. Future trends in outsourcing: a summary of the Bioanalysis Zone Survey.
    Craddock A; Nadarajah S
    Bioanalysis; 2017 Aug; 9(15):1127-1129. PubMed ID: 28766363
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA's poor oversight of postmarketing studies.
    Lancet; 2009 Nov; 374(9701):1568. PubMed ID: 19897111
    [No Abstract]   [Full Text] [Related]  

  • 10. Information Patients Can Provide Will Strengthen the Real-World Evidence That Matters to Them.
    Nowell WB
    Clin Pharmacol Ther; 2019 Jul; 106(1):49-51. PubMed ID: 31112287
    [No Abstract]   [Full Text] [Related]  

  • 11. Decentralized Trials in the Age of Real-World Evidence and Inclusivity in Clinical Investigations.
    Khozin S; Coravos A
    Clin Pharmacol Ther; 2019 Jul; 106(1):25-27. PubMed ID: 31013350
    [No Abstract]   [Full Text] [Related]  

  • 12. What Does It Take to Transform Real-World Data Into Real-World Evidence?
    Ramamoorthy A; Huang SM
    Clin Pharmacol Ther; 2019 Jul; 106(1):10-18. PubMed ID: 31273768
    [No Abstract]   [Full Text] [Related]  

  • 13. Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development.
    Finelli LA; Narasimhan V
    Clin Pharmacol Ther; 2020 Oct; 108(4):756-761. PubMed ID: 32294230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Data, Advanced Analytics, and the Evolution of Postmarket Drug Safety Surveillance.
    Dal Pan GJ
    Clin Pharmacol Ther; 2019 Jul; 106(1):28-30. PubMed ID: 30958565
    [No Abstract]   [Full Text] [Related]  

  • 15. Uniting Discovery and Care: The Role of Pharmaceutical Companies in Research, Clinical Studies, and Patient Care.
    Tan C; McGill JM; Mallbris L
    J Invest Dermatol; 2020 Mar; 140(3):527-530. PubMed ID: 31972248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group.
    Ménard T; Young K; Siegel L; Emerson J; Studt R; Sidor L;
    CPT Pharmacometrics Syst Pharmacol; 2021 Aug; 10(8):799-803. PubMed ID: 34247450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of different logistical approaches to postmarketing surveillance.
    Strom BL
    J Rheumatol Suppl; 1988 Oct; 17():9-13. PubMed ID: 3204621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Digital Health Enable Higher Quality Real-World Evidence-Based Decisions?
    Dickmann LJ; Kothare PA
    Clin Pharmacol Ther; 2019 Jul; 106(1):45-46. PubMed ID: 31013352
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmaceutical industry needs more clinical pharmacologists.
    Peck R
    Br J Clin Pharmacol; 2017 Nov; 83(11):2343-2346. PubMed ID: 28688130
    [No Abstract]   [Full Text] [Related]  

  • 20. The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade.
    Robbins A; Arita I
    Int J Technol Assess Health Care; 1994; 10(1):39-46. PubMed ID: 8157459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.